Deleted in bladder cancer 1 (DBC1) is a candidate gene for the bladder tumour suppressor locus at 9q33.1. The function of the gene is currently unknown but a cross-species sequence comparison suggests ...
Breast cancer profile in patients (pts) seen at two Community Hospitals of Buenos Aires,Argentina, born between 1900 and 1970 ...
Sometimes it's hard to tell friends from foes, biologically speaking. Naturally produced in the body, urokinase plasminogen activator and plasminogen interact to break up blood clots and recruit clean ...
A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...
The effectiveness of various solutions instilled into the central venous catheter lumens after each hemodialysis session (catheter locking solutions) to decrease the risk of catheter malfunction and ...
ROCKVILLE, MARYLAND and LAVAL, QUEBEC--(Marketwired - Oct 28, 2014) - ProMetic Life Sciences Inc. (PLI.TO)(PFSCF) ("ProMetic" or the "Corporation") announced today that the US Food and Drug ...
Fibrinolysis is the break-down of blood clots, which is a crucial part of wound healing. If fibrinolysis is not properly regulated it can lead to numerous different diseases. A blood clot (Thrombus) ...
Scientists have been puzzled by the fact that high levels of plasmin in blood and high levels of urokinase in artery walls are linked to high risk for rapid progression of atherosclerosis and heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback